Serina Therapeutics Debt-to-Assets Ratio Growth & History (SER)

Serina Therapeutics's debt-to-assets ratio was 0.48 for fiscal 2025.

View full Serina Therapeutics company overview

Serina Therapeutics annual debt-to-assets ratio history

Serina Therapeutics annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20252025-12-310.480.41+597.28%
20242024-12-310.07−0.34−83.36%
20232023-12-310.41−5.18−92.63%
20222022-12-315.591.41+33.60%
20212021-12-314.19
20192019-12-310.06

Serina Therapeutics debt-to-assets ratio trends

Between the periods ended 2019-12-31 and 2025-12-31, Serina Therapeutics's debt-to-assets ratio increased from 0.06 to 0.48, a change of 0.42. The latest reported quarter, Q2 2026, shows 0.12.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Serina Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about SER yet. Start the conversation.

Write the first post